This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_PANCREAS_NEUROENDOCRINE_EXALLC for full statistics.
Neuroendocrine tumor and carcinoma of pancreas
C3_PANCREAS_NEUROENDOCRINE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
199 |
4. Check minimum number of eventsNone |
199 |
5. Include endpointsNone |
199 |
6. Filter based on genotype QC (FinnGen only) |
199 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of pancreas
based on the number of shared cases.
Similar with more cases:
- Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of pancreas
- Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 199 | 94 | 105 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | 61.51 | 59.71 | 63.12 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 179
- Matched controls
- 1789
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
254.8
117.2
110
11
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
1209.8
81.0
73
*
130
Kela drug reimbursment
Malignant tumour
24.5
63.3
97
82
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
62.1
56
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
72.5
53.0
59
12
H01CB03
ATC
lanreotide; parenteral
643.6
51.1
48
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
49.3
45
*
8249/3-C25.9
ICD-O-3
Neuroendocrine tumor, grade 2 of pancreas, NOS
+∞
48.1
44
*
L01AX03
ATC
temozolomide; systemic
+∞
45.8
42
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
126.1
45.3
47
5
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
62.2
43.8
50
11
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
115.5
42.0
44
5
WX302
NOMESCO Finland
Thoracal epidural anesthesy
18.9
40.0
64
51
H01CB02
ATC
octreotide; parenteral
441.0
37.4
36
*
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
35.6
33
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
389.7
33.0
32
*
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
200.6
32.9
33
*
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
128.9
30.8
32
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
10.2
30.7
67
99
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
124.0
29.7
31
*
L01BC06
ATC
capecitabine; oral
20.3
29.7
45
29
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
178.7
29.6
30
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
26.7
29.0
40
19
D76
ICPC
Malignant neoplasm pancreas
114.5
27.5
29
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
26.4
27.5
38
18
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
+∞
25.6
24
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
16.2
25.0
41
32
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
24.5
23
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
24.5
23
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
144.2
24.2
25
*
A04AA02
ATC
granisetron; systemic, transdermal
10.4
22.9
47
59
JN4BD
NOMESCO Finland
Extensive body CT
7.9
22.7
57
100
A03FA01
ATC
metoclopramide; systemic, rectal
5.7
22.6
79
216
JN3AD
NOMESCO Finland
Abdominal CT examination
9.7
22.4
48
65
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
25.4
21.7
30
14
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
+∞
21.3
20
*
JN4CD
NOMESCO Finland
Very extensive body CT
11.8
20.7
39
41
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
45.7
20.1
24
6
JMA10
NOMESCO Finland
Transabdominal total splenectomy
118.1
20.0
21
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
18.9
19.1
29
18
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
211.0
18.9
19
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
7.2
18.8
49
89
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
17.9
18.7
29
19
JN4AD
NOMESCO Finland
Body CT examination
8.0
18.4
44
70
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.5
18.3
39
51
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
18.0
17
*
197
Kela drug reimbursment
Sunitinib
+∞
18.0
17
*
158
Kela drug reimbursment
Everolimus
+∞
18.0
17
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.6
17.0
38
54
TPH07
NOMESCO Finland
Cathetrisation of artery
5.9
16.9
52
116
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
99.4
16.9
18
*
JLC00
NOMESCO Finland
Excision of lesion of pancreas
+∞
15.9
15
*
8249/3-C25.2
ICD-O-3
Neuroendocrine tumor, grade 2 of tail of pancreas
+∞
15.9
15
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.8
15.8
42
77
8246/3-C25.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of pancreas, NOS
+∞
14.8
14
*
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
14.8
14
*
B01AB05
ATC
enoxaparin; parenteral
3.7
14.6
88
371
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.5
14.0
31
43
WZC30
NOMESCO Finland
Teaching
4.7
13.9
52
142
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
+∞
13.7
13
*
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
+∞
13.7
13
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
23.4
13.6
19
9
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
13.3
81
340
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
54.1
13.0
15
*
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
+∞
12.6
12
*
L01XE10
ATC
[U] everolimus; oral
+∞
12.6
12
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
+∞
12.6
12
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
139.2
12.6
13
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
23.3
12.3
17
8
103
Kela drug reimbursment
Diabetes, insulin-treated
3.4
11.9
74
307
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
11.8
47
135
8240/3-C25.2
ICD-O-3
Neuroendocrine tumor, NOS, of tail of pancreas
+∞
11.6
11
*
340
Kela drug reimbursment
Everolimus
+∞
11.6
11
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
127.8
11.6
12
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
11.3
105
572
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.3
11.2
69
284
JAH01
NOMESCO Finland
Laparoscopy
9.9
11.1
22
25
N02AA05
ATC
oxycodone; systemic
4.0
10.8
47
146
T73
ICPC
Neoplasm endocrine other/unspecified
+∞
10.5
10
*
L01XE04
ATC
[U] sunitinib; oral
+∞
10.5
10
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
34.8
10.5
13
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
25.1
10.4
14
6
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
25.1
10.4
14
6
T90
ICPC
Diabetes non-insulin dependent
3.2
10.0
64
267
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.9
10.0
81
396
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
27.8
10.0
13
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
9.7
76
361
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
9.6
79
386
E16.10
ICD-10 Finland
Hyperinsulinism
105.3
9.5
10
*
JKA20
NOMESCO Finland
Cholecystectomy
9.1
9.3
19
23
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.1
9.1
59
246
JAH00
NOMESCO Finland
Laparotomy
9.4
9.0
18
21
A10AE04
ATC
insulin glargine; parenteral
4.2
8.9
35
98
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.0
8.7
28
64
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
17.4
8.7
13
8
A04AA01
ATC
ondansetron; systemic, rectal
5.3
8.7
26
55
106
Kela drug reimbursment
Hypoparathyroidism
+∞
8.4
8
*
322
Kela drug reimbursment
Sunitinib
+∞
8.4
8
*
8249/3-C25.0
ICD-O-3
Neuroendocrine tumor, grade 2 of head of pancreas
+∞
8.4
8
*
SPAT1262
SPAT
Handing over of treatment supplies
3.1
8.3
52
209
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
12.5
8.2
14
12
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
8.1
47
178
UJK02
NOMESCO Finland
ERCP
9.1
8.0
16
19
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
47.0
7.8
9
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
12.6
7.7
13
11
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
26.3
7.7
10
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
83.3
7.5
8
*
A10BA02
ATC
metformin; oral
2.6
7.5
65
321
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
+∞
7.3
7
*
BBA50
NOMESCO Finland
Total parathyroidectomy
+∞
7.3
7
*
8249/3-C25.1
ICD-O-3
Neuroendocrine tumor, grade 2 of body of pancreas
+∞
7.3
7
*
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
7.3
7
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
16.6
7.3
11
7
A79
ICPC
Malignancy NOS
21.0
7.2
10
5
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.2
7.0
16
24
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
14.5
7.0
11
8
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
8.8
7.0
14
17
XX3DW
NOMESCO Finland
Time consuming IT work
3.5
6.9
32
104
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
41.6
6.8
8
*
A11CC03
ATC
alfacalcidol; systemic
8.3
6.7
14
18
R10.0
ICD-10 Finland
Acute abdomen
8.3
6.7
14
18
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
23.5
6.7
9
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.2
6.7
25
67
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
12.9
6.7
11
9
B01AB10
ATC
tinzaparin; parenteral
4.4
6.6
23
58
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
72.2
6.5
7
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
72.2
6.5
7
*
E21.0
ICD-10 Finland
Primary hyperparathyroidism
8.7
6.4
13
16
J01MA12
ATC
levofloxacin; systemic
2.7
6.4
48
215
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
18.8
6.3
9
5
V03AH01
ATC
diazoxide; systemic
+∞
6.3
6
*
8246/3-C25.2
ICD-O-3
Neuroendocrine carcinoma, NOS, of tail of pancreas
+∞
6.3
6
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.1
6.2
12
14
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
6.1
49
228
Z51.5
ICD-10 Finland
Palliative care
4.3
6.0
21
53
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
162
24
358.66
307.65
9.8
2.5
nmol/l
45.0
3.0
0.69
162
24
(3000570) Elastase.pancreatic [Mass/mass] in Stool
70
42
25.17
88.40
2.0
1.5
ug/g
198.5
272.5
1.36
59
26
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
58
22
36.80
87.40
4.4
1.4
ug/l
27.1
16.4
1.28
58
22
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
100
181
10.10
59.99
3.6
4.6
ug/l
5.2
30.5
0.56
81
151
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
47
35
17.27
52.04
2.2
1.1
nmol/l
0.7
0.7
0.02
47
30
(4035726)
85
150
9.15
51.21
1.6
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
59
69
11.73
49.15
3.3
3.2
u/ml
715.9
148.7
0.38
54
57
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
136
555
5.58
30.52
5.3
2.7
u/l
75.3
55.7
0.53
130
516
(3024561) Albumin [Mass/volume] in Serum or Plasma
156
719
6.41
30.02
10.5
4.9
g/l
34.7
35.4
0.93
151
674
(3032080) INR in Blood by Coagulation assay
149
664
5.95
29.77
11.5
8.2
inr
1.2
1.2
0.15
50
201
(3035637) Corticotropin [Mass/volume] in Plasma
23
16
16.12
25.77
2.5
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
146
744
4.61
21.85
11.8
6.0
mmol/l
1.2
1.2
0.57
141
675
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
152
810
4.71
21.07
14.4
7.3
mmol/l
1.2
1.2
0.48
124
691
(3018418) pH of Serum or Plasma
111
490
3.86
19.88
8.6
3.9
ph
7.4
7.4
0.27
31
92
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
58
162
4.64
19.74
3.9
2.6
u/l
126.6
30.9
0.95
53
135
(3013826) Glucose [Moles/volume] in Serum or Plasma
164
993
4.70
17.42
9.2
4.9
mmol/l
7.3
6.7
2.92
159
933
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
65
216
3.98
17.32
4.7
3.1
umol/l
8.5
8.0
0.07
57
193
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
137
771
3.49
15.41
5.9
4.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
44
123
4.31
14.66
6.0
3.8
ng/l
60.7
84.0
1.46
37
109
(40768441) Liver Pathology biopsy report
15
14
11.51
13.92
1.0
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
94
472
2.88
12.03
6.8
4.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
102
544
2.80
11.51
10.5
3.5
mmol/l
2.4
2.4
0.29
96
466
(3044640) Blood type and Crossmatch panel - Blood
100
531
2.78
11.33
3.0
2.4
—
—
—
0
0
(3020891) Body temperature
27
63
4.80
11.16
6.4
4.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
147
987
2.87
9.98
21.6
9.3
e9/l
4.2
4.1
0.25
138
876
(3008152) Bicarbonate [Moles/volume] in Arterial blood
34
104
3.74
9.84
11.4
7.8
mmol/l
25.3
24.9
0.41
34
99
(42870588) Differential panel, method unspecified - Blood
99
558
2.54
9.50
8.3
5.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
23
6.97
9.49
2.2
1.4
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
23
6.97
9.49
2.1
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
35
113
3.54
9.34
8.3
4.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
117
3.42
8.84
3.7
3.6
ng/l
136.8
242.7
1.06
28
105
(40758558) Short blood count panel - Blood
79
412
2.52
8.80
16.7
6.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
47
191
2.91
8.54
8.4
8.2
mmol/l
1.8
1.1
0.50
41
158
(3006315) Basophils [#/volume] in Blood
128
843
2.45
8.36
9.8
5.6
e9/l
0.0
0.0
0.50
114
738
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
53
233
2.74
8.30
2.5
2.4
%
18.6
22.4
1.25
45
201
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
14
8.26
8.07
3.9
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
127
843
2.40
8.01
9.9
5.5
e9/l
0.6
0.6
1.08
113
737
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
46
192
2.82
7.92
8.5
8.0
kpa
5.3
5.2
0.37
46
186
(3027801) Oxygen [Partial pressure] in Arterial blood
46
192
2.82
7.92
8.5
8.0
kpa
13.7
11.9
1.21
46
187
(3021589) Normoblasts [#/volume] in Blood
117
752
2.35
7.92
21.4
9.5
e9/l
0.0
0.0
0.14
103
614
(3013115) Eosinophils [#/volume] in Blood
129
867
2.39
7.84
9.9
5.9
e9/l
0.2
0.2
0.58
117
773
(3019198) Lymphocytes [#/volume] in Blood
128
862
2.36
7.67
10.0
5.6
e9/l
2.0
1.9
0.38
116
769
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
395
2.39
7.65
2.5
2.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
87
502
2.30
7.48
3.0
3.2
mmol/l
6.7
7.9
1.95
75
417
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
94
598
2.08
6.00
3.2
3.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
32
4.63
5.86
2.4
2.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
56
293
2.27
5.86
8.2
2.9
mmol/l
2.5
2.4
1.37
49
254
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
33
4.49
5.66
1.0
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
43
205
2.40
5.54
1.5
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
82
509
2.04
5.48
3.9
4.1
mg/mmol
10.4
8.9
0.13
56
332
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
22
5.23
5.32
1.7
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
78
481
2.02
5.27
3.1
3.3
mg/l
41.7
52.9
0.26
58
328
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
82
523
1.97
4.98
3.3
3.3
ng/l
726.0
1105.5
0.66
73
426
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
42
3.78
4.87
1.9
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
147
1154
2.05
4.72
6.0
3.3
u/l
89.3
53.8
1.16
141
1082
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
48
3.54
4.71
1.6
2.4
u/ml
0.3
0.4
—
9
27
(3002582) Erythrocytes [#/volume] in Urine
79
507
1.93
4.64
3.5
3.1
e6/l
12.7
52.5
2.19
63
386
(36304419) Bacteria [Presence] in Urine
72
449
1.95
4.60
2.8
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
36
175
2.29
4.40
5.3
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
149
1189
2.01
4.38
5.0
3.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
65
398
1.94
4.35
2.7
2.0
mg/l
3.0
3.3
0.27
57
338
(3013005) Retinol [Moles/volume] in Serum or Plasma
7
6
12.03
4.31
1.6
2.0
umol/l
2.1
1.9
—
7
6
(3042936) Bacteria identified in Isolate by Culture
47
259
2.07
4.21
2.3
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
140
1109
1.89
4.01
3.9
4.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
94
666
1.78
3.86
2.6
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
72
471
1.83
3.86
3.2
3.0
e6/l
0.4
0.6
0.41
57
341
(3018095) Leukocytes [#/volume] in Urine
84
577
1.79
3.82
3.7
3.6
e6/l
80.7
68.5
0.11
66
414
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
8
9.01
3.80
1.6
1.8
umol/l
29.4
29.1
—
7
8
(40768797) Stomach Pathology biopsy report
43
239
2.02
3.74
1.5
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
134
2.27
3.54
4.0
3.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
58
369
1.81
3.34
1.9
1.8
mg/l
1.5
1.4
0.29
46
296
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
112
2.30
3.22
1.9
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
16
5.16
3.08
1.4
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
65
442
1.70
2.93
4.0
3.6
estimate
0.0
0.0
0.00
25
149
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
86
630
1.64
2.91
4.2
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
184
1663
2.41
2.85
33.9
14.6
mg/l
35.0
23.9
3.85
170
1308
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
6
8.51
2.76
4.6
2.0
ug/l
0.6
1.6
—
5
6
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
143
2.03
2.67
6.9
3.1
ml/min/173m2
74.7
63.1
1.42
15
64
(3041096) Erythrocytes [Presence] in Urine by Automated
65
454
1.64
2.61
3.8
3.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
91
690
1.59
2.61
4.2
3.9
ng/l
37.7
47.9
0.23
72
497
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
96
2.20
2.53
13.7
9.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
57
390
1.65
2.46
4.1
4.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
52
348
1.67
2.44
1.6
1.7
pmol/l
463.1
450.9
0.07
42
289
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
12
5.12
2.42
1.0
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
35
2.96
2.34
6.3
2.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
86
661
1.53
2.24
2.2
2.0
pmol/l
87.4
94.6
0.81
55
350
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
24
3.43
2.20
1.3
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
19
3.78
2.17
1.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
14
4.38
2.16
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
44
2.59
2.05
1.4
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
61
447
1.53
1.93
1.4
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
175
1601
1.77
1.88
29.9
13.3
ml/min/173m2
82.6
80.6
0.70
166
1324
(3026008) Bacteria identified in Urine by Culture
63
468
1.51
1.87
2.8
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
40
2.58
1.86
1.7
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
104
1.91
1.74
1.8
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
24
142
1.78
1.74
6.2
8.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
48
2.37
1.74
1.3
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
48
2.37
1.74
1.3
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
191
1.67
1.69
1.6
2.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
97
797
1.42
1.67
4.0
3.5
estimate
0.0
0.0
0.00
29
156
(3021601) Nitrite [Presence] in Urine by Test strip
97
799
1.42
1.64
5.2
4.7
estimate
0.0
0.0
0.00
28
158
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
140
1232
1.46
1.64
5.2
3.8
pmol/l
14.5
14.8
0.48
134
1088
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
194
1.64
1.60
1.7
2.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
26
2.75
1.59
2.9
3.0
e9/l
3.9
5.1
—
7
26
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
26
2.75
1.59
3.1
3.7
%
56.4
59.5
—
7
26
(3009261) Glucose [Presence] in Urine by Test strip
98
813
1.40
1.57
4.0
3.5
estimate
0.0
0.0
0.00
27
150
(3026389) Candida sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.2
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
27
2.65
1.53
1.4
2.4
%
51.2
62.7
—
7
27
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
21
2.91
1.51
1.5
1.6
pg
29.2
33.1
—
6
21
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
275
1.52
1.46
1.7
2.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
23
143
1.69
1.43
3.2
3.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
67
2.01
1.42
2.4
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
25
160
1.64
1.40
3.8
4.0
mmol/l
1.8
1.7
0.05
19
123
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
43
313
1.48
1.39
3.7
3.8
ng/l
129.1
165.6
0.18
30
248
(3007566) Smooth muscle Ab [Titer] in Serum
10
47
2.19
1.36
1.1
1.2
—
54.0
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
92
1.80
1.29
1.0
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
25
164
1.60
1.28
3.8
4.0
kpa
5.7
5.7
0.04
25
159
(21494755) Public health laboratory ask at order entry panel
7
142
0.47
1.26
1.1
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
143
0.47
1.26
2.0
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
43
319
1.44
1.26
1.9
1.7
nmol/l
1186.7
1166.3
0.05
37
241
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
38
276
1.47
1.24
2.7
3.0
e6/l
1.8
2.1
0.13
18
144
(3000494) Fungus identified in Specimen by Culture
29
199
1.54
1.23
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
165
1528
1.47
1.22
5.6
4.5
mu/l
2.0
1.9
0.27
152
1370
(3013707) Erythrocyte sedimentation rate by Westergren method
139
1251
1.37
1.22
3.5
4.1
mm/h
13.5
11.6
0.57
124
1139
(3012544) pH of Venous blood
25
167
1.57
1.19
4.4
4.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
183
1735
1.68
1.18
34.6
14.1
—
—
—
0
0
(3013512) EKG study
64
516
1.35
1.16
5.1
4.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
20
2.54
1.16
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
174
1635
1.51
1.12
7.5
4.6
mmol/l
6.8
6.0
6.91
168
1491
(3024354) Oxygen [Partial pressure] in Venous blood
21
137
1.60
1.11
4.1
2.8
kpa
4.7
4.2
0.37
21
131
(3025159) Blasts/100 leukocytes in Blood
19
122
1.62
1.07
3.3
5.1
%
0.0
0.0
—
6
36
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
33
2.16
1.06
3.6
8.9
—
176.4
—
0
7
(44790049)
5
22
2.30
1.04
1.2
1.6
—
—
—
0
0
(44790047)
5
22
2.30
1.04
1.2
1.6
—
—
—
0
0
(44806118)
5
22
2.30
1.04
1.2
1.6
—
—
—
0
0
(44790048)
5
22
2.30
1.04
1.2
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
34
2.10
1.04
1.3
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
35
2.04
1.01
1.6
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
18
116
1.61
1.00
6.6
3.7
kpa
5.5
5.1
1.10
18
106
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
31
0.00
0.97
0.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
7
37
1.92
0.95
4.9
2.3
kpa
8.4
7.9
—
7
32
(3009542) Hematocrit [Volume Fraction] of Blood
160
1494
1.36
0.94
30.2
15.5
%
38.4
39.9
1.43
117
1077
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
13
78
1.71
0.94
3.1
3.9
mmol/l
24.6
24.1
0.16
13
69
(3019150) Specific gravity of Urine by Refractometry
44
346
1.35
0.93
4.3
3.6
kg/l
1.0
1.0
2.06
11
41
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
17
251
0.65
0.92
1.1
1.2
u/ml
1.5
12.1
—
9
100
(3021901) Oxygen saturation in Capillary blood
6
28
2.18
0.92
5.0
2.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
103
0.47
0.92
2.2
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
8
43
1.90
0.88
6.3
2.5
mmol/l
26.2
25.5
—
8
35
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
43
1.90
0.88
1.8
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
28
207
1.41
0.85
2.0
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
31
1.96
0.85
1.7
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
5
98
0.50
0.80
1.2
1.3
u/ml
115.6
158.8
—
5
85
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
28
211
1.38
0.77
1.8
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
91
1.58
0.77
2.9
2.5
%
0.9
1.3
1.07
14
91
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
38
301
1.32
0.77
2.5
2.7
e6/l
0.8
1.0
0.30
18
167
(3024928) Oxygen saturation in Venous blood
6
34
1.79
0.77
4.7
2.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.2
—
294.1
—
0
14
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
131
0.59
0.76
1.0
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
24
2.11
0.75
1.2
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
26
195
1.38
0.74
1.2
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
39
1.82
0.73
1.6
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
39
1.82
0.73
1.0
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
85
1.57
0.71
1.6
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
28
1.81
0.66
1.8
2.8
mmol/l
104.0
106.3
—
5
28
(3014051) Protein [Presence] in Urine by Test strip
5
28
1.81
0.66
2.2
1.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
28
1.81
0.66
1.8
2.8
mmol/l
4.1
4.0
—
5
28
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
28
1.81
0.66
1.8
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
25
191
1.35
0.65
1.8
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
79
1.55
0.64
3.8
3.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
51
1.59
0.61
4.1
4.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
52
1.56
0.60
1.4
2.5
mg/l
1.6
1.6
—
8
44
(3026493) Urate [Moles/volume] in Serum or Plasma
52
445
1.23
0.58
2.3
2.8
umol/l
354.4
7726.5
1.98
46
380
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
125
0.63
0.56
3.0
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
60
1.52
0.55
1.8
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
19
143
1.36
0.55
3.3
4.8
%
0.7
0.8
—
7
47
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
13
91
1.46
0.54
6.5
10.6
mmol/l
25.5
24.6
0.27
13
86
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
132
0.67
0.54
3.0
1.7
—
—
—
0
0
(3019225) pH of Specimen
22
171
1.32
0.52
10.9
4.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
40
1.52
0.52
1.2
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
110
1.39
0.50
2.2
2.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
19
146
1.33
0.49
2.4
2.5
ug/l
5.7
8.1
0.33
19
127
(3021440) Promyelocytes/100 leukocytes in Blood
17
129
1.35
0.47
3.6
5.0
%
0.0
0.2
—
6
43
(3002179) Metamyelocytes/100 leukocytes in Blood
17
130
1.34
0.45
2.7
4.8
%
0.3
0.3
—
6
32
(3005719) IgG [Mass/volume] in Serum or Plasma
9
129
0.68
0.45
1.2
2.3
g/l
9.9
10.7
—
9
115
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
158
1.30
0.44
1.4
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
88
1.39
0.41
8.7
3.8
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
97
1.36
0.40
2.2
2.0
—
—
—
0
0
(4010399)
10
137
0.72
0.40
1.1
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
68
1.34
0.38
1.0
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
276
0.81
0.37
1.0
1.2
iu/ml
15.8
39.1
—
7
93
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
200
1.23
0.35
1.7
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
36
410
0.85
0.34
2.5
3.1
ug/l
0.9
0.8
0.27
22
265
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
10
74
1.37
0.33
8.6
4.5
mmol/l
24.9
25.2
—
10
68
(3052851) Hemolysis interference index of Serum or Plasma
7
55
1.28
0.30
2.7
3.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
55
1.28
0.30
1.6
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
107
0.74
0.30
1.0
1.2
—
31.0
—
0
5
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
172
1680
1.18
0.29
5.0
5.2
mmol/l
2.5
2.8
3.80
163
1548
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
75
0.66
0.26
1.0
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
40
363
1.13
0.23
3.3
3.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
38
1.32
0.23
1.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
56
602
0.90
0.23
3.0
3.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
41
1.23
0.22
1.2
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
19
219
0.85
0.21
1.2
1.3
titre
288.0
584.7
—
5
55
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.5
—
48.2
—
0
11
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
22
250
0.87
0.21
2.0
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
71.1
—
0
7
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
13
0.00
0.21
0.0
2.5
—
13.4
—
0
13
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
6
50
1.21
0.20
2.7
3.7
—
4.0
—
0
5
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
50
1.21
0.20
1.3
1.6
—
—
—
0
0
(4094501)
6
51
1.18
0.19
1.3
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
163
1599
1.11
0.18
4.4
4.1
mmol/l
1.4
1.3
0.96
156
1468
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.18
2.1
3.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
67
0.74
0.17
1.4
2.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
168
1652
1.11
0.16
4.8
4.6
mmol/l
4.3
4.6
4.43
162
1533
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
167
1643
1.10
0.15
4.6
4.6
mmol/l
1.4
1.4
1.51
161
1513
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
70
675
1.06
0.11
3.9
5.2
ug/l
2.0
2.6
0.50
62
612
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
116
1.13
0.09
1.2
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
101
987
1.05
0.09
2.9
3.0
—
—
—
0
0
(3000492) Spirometry study
14
154
0.90
0.08
1.4
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
64
0.78
0.08
1.4
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
81
0.86
0.07
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
30
315
0.94
0.07
1.5
1.4
g/l
2.5
2.5
0.02
18
189
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
264
0.94
0.06
1.3
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
100
0.90
0.06
1.3
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
10
110
0.90
0.05
1.0
1.6
g/l
0.8
1.5
—
10
99
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
36
348
1.04
0.04
1.6
1.2
u/ml
2.7
1.8
0.23
13
102
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
53
542
0.97
0.04
3.1
4.4
%
26.0
20.9
1.34
27
258
(36660697) Celiac disease serology panel - Serum
13
124
1.05
0.00
1.5
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
225
0.98
0.00
3.8
4.7
%
33.7
31.9
0.23
16
150
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
215
1.03
0.00
16.5
8.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
9
0.00
0.00
0.0
8.1
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
231.3
—
0
9
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
7.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
9.9
—
0
6
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.0
—
4.6
—
0
6
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
99.0
—
0
5
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
89
0.89
0.00
2.1
2.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
95
0.94
0.00
1.0
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PANCREAS_NEUROENDOCRINE – Neuroendocrine tumor and carcinoma of pancreas
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).